{"id":"homocamfin","rwe":[],"tags":[{"label":"homocamfin","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"hexeton","offLabel":[],"synonyms":["homocamfin","cyclosal","hexeton","hexetone"],"timeline":[],"approvals":[],"brandName":"Hexeton","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"homocamfin","explanation":"Imagine your body's cells have locks on them, and the key to unlocking the right response is a specific molecule. Hexeton is designed to fit into this lock, allowing the cell to respond in a way that treats the underlying condition. This is a simplified explanation of how many medications work, including Hexeton.","oneSentence":"Hexeton is thought to work by interacting with a specific molecular target to produce its therapeutic effect.","technicalDetail":"The exact mechanism of action of Hexeton is not well-documented, but it is believed to interact with a specific molecular target to produce its therapeutic effect. Further research is needed to fully understand its pharmacology."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3755","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=homocamfin","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T13:51:59.829912","biosimilars":[],"competitors":[],"genericName":"homocamfin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"1PTJ9TO8ZZ","CHEBI":"CHEBI:134777","PUBCHEM_CID":"222994"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Hexeton, also known as homocamfin, is a small molecule drug of the homocamfin class. Its mechanism of action and approved indications are not well-documented, and it is unclear if it has been approved by the FDA. As a result, there is limited information available on its commercial status, safety considerations, or pharmacokinetic properties. Further research is needed to fully understand this compound. Its development history is also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}